FDA: Contrave diet pill data lacks cardio insight; 10k sample search seeks diabetes tipoff;

> Orexigen meets with an FDA panel Tuesday about the diet pill Contrave and its lack of data to evaluate long-term cardiovascular risks. Trials were too short and small and included too few participants had a history of heart disease, according to agency documents posted ahead of the meeting. Article

> In an effort to predict T1 diabetes susceptibility, Oxford Gene Technology will work with the University of Virginia to canvass 10,000 patient samples for genomic variations. Story

> Recruitment software specialist DecisionView has launched version 4.2 of the StudyOptimizer solution for patient enrollment planning, tracking and forecasting. DecisionView release

> Transgenomic is buying Clinical Data's diagnostics business. News

> Cosmo Pharmaceuticals reports positive results from a Phase III clinical study, for which it used DATATRAK's unified eClinical product suite and services, evaluating ulcerative colitis treatment budesonide MMX. Cosmo release

> Virtify is preparing to release Virtify for Submissions, a structured content management software platform for regulatory submission documents. Virtify announcement

> InnovoCommerce announces version 3.1 of the SharePoint-based innovoPOINT clinical and investigator portal for secure document exchange and clinical trial business process automation. InnovoCommerce release

> Clinical data management consultancy Eliassen Group has acquired the IT staffing division of Dextrys, a provider of product engineering and application services outsourcing. Eliassen release

> Southampton University School of Medicine is using radio chromatography systems from LabLogic in the development of radio-labeled antibody conjugates for treating hematological malignancies. LabLogic announcement 

> CTMS supplier BioClinica welcomes oncology-focused CRO Kaizen Clinical Services to the BioClinica Certified Partner Program. Kaizen announcement

> Global CRO Rho joins Medidata's ASPire to Win channel partner program. Medidata announcement

> Mark Lanfear joins Advanced Clinical as VP for clinical operations. Advanced Clinical announcement

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.